ArticleFrontiers in digital health2022
Evaluating the COVID-19 Identification ResNet (CIdeR) on the INTERSPEECH COVID-19 From Audio Challenges.
Article in Frontiers in digital health, 2022. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 3 papers.
What it found
Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.
The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.
The trial behind it
Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.
Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.
Who cites it
3 citing papers in PubMed.
- Development and Validation of a Respiratory-Responsive Vocal Biomarker-Based Tool for Generalizable Detection of Respiratory Impairment: Independent Case-Control Studies in Multiple Respiratory Conditions Including Asthma, Chronic Obstructive Pulmonary Disease, and COVID-19.Journal of medical Internet research · 2023Article
- Deep learning on multi-view sequential data: a survey.Artificial intelligence review · 2023Article
- A summary of the ComParE COVID-19 challenges.Frontiers in digital health · 2023Article
Corrections and comments
PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.
Authors and funding
6 authors.
Funding
No grant is acknowledged in the PubMed record.
Abstract
Several machine learning-based COVID-19 classifiers exploiting vocal biomarkers of COVID-19 has been proposed recently as digital mass testing methods. Although these classifiers have shown strong performances on the datasets on which they are trained, their methodological adaptation to new datasets with different modalities has not been explored. We report on cross-running the modified version of recent COVID-19 Identification ResNet (CIdeR) on the two Interspeech 2021 COVID-19 diagnosis from cough and speech audio challenges: ComParE and DiCOVA. CIdeR is an end-to-end deep learning neural network originally designed to classify whether an individual is COVID-19-positive or COVID-19-negative based on coughing and breathing audio recordings from a published crowdsourced dataset. In the current study, we demonstrate the potential of CIdeR at binary COVID-19 diagnosis from both the COVID-19 Cough and Speech Sub-Challenges of INTERSPEECH 2021, ComParE and DiCOVA. CIdeR achieves significant improvements over several baselines. We also present the results of the cross dataset experiments with CIdeR that show the limitations of using the current COVID-19 datasets jointly to build a collective COVID-19 classifier.
Indexed as
Identifiers
What OpenQuestion holds
Registered trials
Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.